Abstract PD11-08: Time Implications of an Oncology Intelligence Platform vs Standard Practice: A UK Single Centre Breast Cancer Multi Disciplinary Team Meeting Simulation Trial

Abstract Background Multi-Disciplinary Team Meetings (MDTMs) are "gold standard" in the UK cancer care continuum. The National Health Service (NHS) England conducts 55,000 MDTMs annually, consuming over 1.2 million hours of clinician time. This involves pre MDTM case preparation to discussion during MDTM. At the Isle of Wight (IOW), weekly breast cancer MDTMs typically review 30-40 cases over Microsoft (MS) Teams as standard practice, occupying ∼2 hours of clinicians’ time. For the same case volumes, case preparation requires an estimated 50-80 hours per week across three key roles: surgeon, radiologist, and pathologist. The OncoflowTM platform uses Artificial Intelligence, primarily large language models (LLMs) to perform Data Extraction and Treatment Matching to assist Cancer MDTMs. A simulation trial was performed with the objective of evaluating time savings benefit of this platform against standard practice in MDTM case preparation. Methods 2 prospective, synchronous, simulation (non-EHR/Electronic Health Record integrated) breast cancer MDTMs were conducted via MS Teams in 2 phases. The MDT consisted of 1 MDT Coordinator, 1 Surgeon, 1 Medical Oncologist and Radiation Oncologist equivalent from the IOW. Phase 1 was the Standard Arm whereas Phase 2 was the Intervention Arm which implemented the OncoflowTM AI powered Cancer MDTM Coordinator CoPilot software platform, a class 1 UKCA (UK Conformity Assessed) MHRA (Medicines and Healthcare products Regulatory Agency) registered medical device (RN 32434). A set of 10 breast cancer cases each were discussed in each Arm. These were different cases but complexity matched, equal number of "simple" (5), "edge" (2) and "complex" (3). These had variable stage of disease - 5 each of early post-operative and metastatic. Results OncoFlow achieved 100% accuracy in LLM-assisted data extraction and parameter validation. Standard vs Intervention had following time implications - the entire MDTM case preparation time was 120 minutes vs 38 seconds and active MDTM case discussion lasted 29 vs 26 minutes. Dissecting further, these were 14m 7s vs 8m 17s for the 5 “Simple” cases, 5m 12s vs 5m 40s for the 2 “Edge” cases and 10m 26s vs 12m 20s for the 3 “Complex” cases. Projecting these results to the Real-World IOW Breast Cancer MDTM of 30-40 cases meant Case Preparation Time Savings of 6-8 hours/meeting and 310-414 hours annually. A paired T-Test proved that this is statistically significant vs standard practice (p=0.000000002535; 95% CI: 10.77,13.11). Using OncoFlow, time savings of 35-47 minutes/MDTM and 30-40 hours/year were noted during Simple Case active discussion along with 12-16 minutes/meeting and 10-14 hours/year of Net MDT time. Complex Case Discussions were longer, i.e., 19-25 minutes/MDTM and 16-22 hours/year vs standard. Conclusion The OncoflowTM Intelligent Platform was 190 times faster than standard manual case preparation for MDTM presentation. It also demonstrated MDTM time streamlining implications - cutting “simple” case discussion time by 40% and creating more capacity for highly robust “complex” case discussions with a 20% time surplus. These findings are aligned well with the NHS England 2020 Streamlining MDTMs guidance. Engagement with other sites nationally is ongoing for a multicentre, national, simulation MDTM experience with greater sample size. Citation Format: J. Tan, L. Cook, R. Williams, A. Khan, A. Tiwari, P. Garodia, M. Hasanova, B. Lamb, O. Ayodele, S. Adomah, G. Langton, R. Pearson, A. Ghose, A. Maniam. Time Implications of an Oncology Intelligence Platform vs Standard Practice: A UK Single Centre Breast Cancer Multi Disciplinary Team Meeting Simulation Trial [abstract]. In: Proceedings of the San Antonio Breast Cancer Symposium 2025; 2025 Dec 9-12; San Antonio, TX. Philadelphia (PA): AACR; Clin Cancer Res 2026;32(4 Suppl):Abstract nr PD11-08.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2026-02-17
DOI
https://doi.org/10.1158/1557-3265.sabcs25-pd11-08
Primary Topic
Artificial Intelligence in Healthcare and Education
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract PD11-08: Time Implications of an Oncology Intelligence Platform vs Standard Practice: A UK Single Centre Breast Cancer Multi Disciplinary Team Meeting Simulation Trial

Benjamin W. Lamb, Sarah Adomah, Adan Khan, G. Langton et al.
Clinical Cancer Research
Artificial Intelligence in Healthcare and Education
article

Abstract PD11-08: Time Implications of an Oncology Intelligence Platform vs Standard Practice: A UK Single Centre Breast Cancer Multi Disciplinary Team Meeting Simulation Trial

Benjamin W. Lamb, Sarah Adomah, Adan Khan, G. Langton, Aaditya Tiwari, Lorna Cook, M. Hasanova, A. Maniam, A. Ghose, J. Tan, O. Ayodele, P. Garodia, R. Pearson, R. Williams
article en

Abstract

Abstract Background Multi-Disciplinary Team Meetings (MDTMs) are "gold standard" in the UK cancer care continuum. The National Health Service (NHS) England conducts 55,000 MDTMs annually, consuming over 1.2 million hours of clinician time. This involves pre MDTM case preparation to discussion during MDTM. At the Isle of Wight (IOW), weekly breast cancer MDTMs typically review 30-40 cases over Microsoft (MS) Teams as standard practice, occupying ∼2 hours of clinicians’ time. For the same case volumes, case preparation requires an estimated 50-80 hours per week across three key roles: surgeon, radiologist, and pathologist. The OncoflowTM platform uses Artificial Intelligence, primarily large language models (LLMs) to perform Data Extraction and Treatment Matching to assist Cancer MDTMs. A simulation trial was performed with the objective of evaluating time savings benefit of this platform against standard practice in MDTM case preparation. Methods 2 prospective, synchronous, simulation (non-EHR/Electronic Health Record integrated) breast cancer MDTMs were conducted via MS Teams in 2 phases. The MDT consisted of 1 MDT Coordinator, 1 Surgeon, 1 Medical Oncologist and Radiation Oncologist equivalent from the IOW. Phase 1 was the Standard Arm whereas Phase 2 was the Intervention Arm which implemented the OncoflowTM AI powered Cancer MDTM Coordinator CoPilot software platform, a class 1 UKCA (UK Conformity Assessed) MHRA (Medicines and Healthcare products Regulatory Agency) registered medical device (RN 32434). A set of 10 breast cancer cases each were discussed in each Arm. These were different cases but complexity matched, equal number of "simple" (5), "edge" (2) and "complex" (3). These had variable stage of disease - 5 each of early post-operative and metastatic. Results OncoFlow achieved 100% accuracy in LLM-assisted data extraction and parameter validation. Standard vs Intervention had following time implications - the entire MDTM case preparation time was 120 minutes vs 38 seconds and active MDTM case discussion lasted 29 vs 26 minutes. Dissecting further, these were 14m 7s vs 8m 17s for the 5 “Simple” cases, 5m 12s vs 5m 40s for the 2 “Edge” cases and 10m 26s vs 12m 20s for the 3 “Complex” cases. Projecting these results to the Real-World IOW Breast Cancer MDTM of 30-40 cases meant Case Preparation Time Savings of 6-8 hours/meeting and 310-414 hours annually. A paired T-Test proved that this is statistically significant vs standard practice (p=0.000000002535; 95% CI: 10.77,13.11). Using OncoFlow, time savings of 35-47 minutes/MDTM and 30-40 hours/year were noted during Simple Case active discussion along with 12-16 minutes/meeting and 10-14 hours/year of Net MDT time. Complex Case Discussions were longer, i.e., 19-25 minutes/MDTM and 16-22 hours/year vs standard. Conclusion The OncoflowTM Intelligent Platform was 190 times faster than standard manual case preparation for MDTM presentation. It also demonstrated MDTM time streamlining implications - cutting “simple” case discussion time by 40% and creating more capacity for highly robust “complex” case discussions with a 20% time surplus. These findings are aligned well with the NHS England 2020 Streamlining MDTMs guidance. Engagement with other sites nationally is ongoing for a multicentre, national, simulation MDTM experience with greater sample size. Citation Format: J. Tan, L. Cook, R. Williams, A. Khan, A. Tiwari, P. Garodia, M. Hasanova, B. Lamb, O. Ayodele, S. Adomah, G. Langton, R. Pearson, A. Ghose, A. Maniam. Time Implications of an Oncology Intelligence Platform vs Standard Practice: A UK Single Centre Breast Cancer Multi Disciplinary Team Meeting Simulation Trial [abstract]. In: Proceedings of the San Antonio Breast Cancer Symposium 2025; 2025 Dec 9-12; San Antonio, TX. Philadelphia (PA): AACR; Clin Cancer Res 2026;32(4 Suppl):Abstract nr PD11-08.

Clinical Cancer ResearchVol. 32(4_Supplement)
Department of Health and Social Care (GB), Royal Marsden NHS Foundation Trust (GB), University of Leicester (GB), Medway School of Pharmacy (GB), University of Kent (GB), General Medical Council (GB), Princess Alexandra Hospital NHS Trust (GB), Isle of Wight NHS Trust (GB), Clatterbridge Cancer Centre NHS Foundation Trust (GB), University of Manchester (GB), London Cancer (GB), The London College (GB), NIHR Leicester Biomedical Research Centre (GB), University College London (GB), Health and Safety Executive (GB)
Good health and well-being
Openalex Percentile: Top 54%
Artificial Intelligence in Healthcare and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.